Chiesi pro doorzoeken  

Journal Respi no. 03, 2024

Dans ce Journal Respi, nous aborderons les sujets suivants : nanoparticules pour traiter les maladies pulmonaires, une toux chronique, la pollution de l'air, nutrition et exercice physique dans la BPCO et campagne médiatique.

Dans ce Journal Respi

  • Nanoparticules pour traiter maladies pulmonaires1
  •  Une toux chronique2
  • La pollution de l'air3
  • Nutrition et exercice physique dans la BPCO4
  • Campagne médiatique5

Les références

1; Junliang Zhu et al., Inhaled immunoantimicrobials for the treatment of chronic obstructive pulmonary disease.Sci. Adv.10,eabd7904(2024). 

2;  Hazim Abozid et al., Prevalence of chronic cough, its risk factors and population attributable risk in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study. eClinicalMedicine 2024;68: 102423 Published Online 21 January 2024.

3; Demoury, C., Aerts, R., Berete, F. et al. Impact of short-term exposure to air pollution on natural mortality and vulnerable populations: a multi-city case-crossover analysis in Belgium. Environ Health 23, 11 (2024).

4;  Bente Brauwers et al., Combined Exercise Training and Nutritional Interventions or Pharmacological Treatments to Improve Exercise Capacity and Body Composition in Chronic Obstructive Pulmonary Disease: A Narrative Review, in: Nutrients, Volume 15, issue 24 (2023). 


1588/TCP/RES/BE/03-2024 – APR 2024

Confirm access

To gain access to this information we need to confirm that you are a registered practitioner, please provide your registration number.

Your registration number consists of 8 digits

Based on the Code of Conduct for Medicines Advertising, Chiesi may only share certain information with professionals. We check this on the basis of your RIZIV registration.

Pagina beoordelen

Wij zijn benieuwd naar uw mening en ervaring. Om die reden vragen wij u om een beoordeling achter te laten.